Gene-sequencing giant Illumina is teaming up with IBM Watson to analyze your genes

Illumina’s MiSeq sequencing machine.Sam Hodgson/Reuters Artificial intelligence is coming to genetic sequencing.  Gene-sequencing company Illumina is teaming up with IBM Watson Health to put Watson’s artificial intelligence to work analyzing Illumina’s solid tumor sequencing panel. Here’s how it works: A cancer doctor will take a sample of a person’s solid tumor, which will then be sequenced using Illumina’s “TruSight Tumor 170” panel, which will screen for 170 different tumor mutations. Once that happens, Watson will get to work analyzing them and giving back a report to the oncologist, giving them information about the mutations the test found and what the next step might be. “We’re partnering with IBM Watson to take data that comes out of those tests and leverage deep learning algorithms and and cognitive learning algorithms to be within minutes…


Link to Full Article: Gene-sequencing giant Illumina is teaming up with IBM Watson to analyze your genes

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!